Neogen (NEOG)

Company Profile

NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. NEOGEN's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

Company profile

Ticker

NEOG

Exchange

NASDAQ

Website

www.neogen.com

CEO

John Adent

Incorporated

Michigan

Location

Michigan

Fiscal year end

May 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances

Ortho Clinical Diagnostics • QuidelOrtho • Idexx Laboratories • Myriad Genetics • Lantheus • Celldex Therapeutics • Meridian Bioscience • Lucira Health • Heska Corp. • Intellia Therapeutics ...

SEC CIK

0000711377

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

WHERE INCORPORATED • Abbott Analytical Limited • Abtek (Biologicals) Limited • Acumedia Manufacturers, Inc. • CAP IM Supply, LLC • CAP Supply, LLC • Chem-Tech, Ltd. • Delf Chem Solutions, Ltd. • Delf (UK) Limited • Falcon New OpCo, LLC ...

IRS number

382367843

NEOG stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

Conflict minerals disclosure

30 May 23

8-K

Departure of Directors or Certain Officers

4 Apr 23

Neogen Announces Third-Quarter 2023 Results

9 Jan 23

Neogen Announces Second-Quarter 2023 Results

5 Jan 23

8-K

Regulation FD Disclosure

30 Nov 22

8-K

Submission of Matters to a Vote of Security Holders

Neogen Announces First Quarter Results

28 Sep 22

Transcripts

View all

NEOG

Earnings call transcript

2023 Q3

30 Mar 23

NEOG

Earnings call transcript

2023 Q2

5 Jan 23

NEOG

Earnings call transcript

2023 Q1

27 Sep 22

NEOG

Earnings call transcript

2022 Q4

26 Jul 22

NEOG

Earnings call transcript

2021 Q3

24 Mar 22

NEOG

Earnings call transcript

2022 Q2

21 Dec 21

NEOG

Earnings call transcript

2022 Q1

21 Sep 21

NEOG

Earnings call transcript

2021 Q4

20 Jul 21

NEOG

Earnings call transcript

2021 Q3

23 Mar 21

NEOG

Earnings call transcript

2021 Q2

22 Dec 20

Latest ownership filings

View all

SUSQUEHANNA SECURITIES, LLC

Financial summary

Financial statements Chart NEOG financial data

Quarter (USD)	Feb 23	Nov 22	Aug 22	May 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	May 22	May 21	May 20	May 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	67.13 mm	67.13 mm	67.13 mm	67.13 mm	67.13 mm	67.13 mm
Cash burn (monthly)	10.96 mm	(no burn)	(no burn)	(no burn)	5.69 mm	2.46 mm
Cash used (since last report)	35.62 mm	n/a	n/a	n/a	18.50 mm	8.01 mm
Cash remaining	31.52 mm	n/a	n/a	n/a	48.64 mm	59.13 mm
Runway (months of cash)	2.9	n/a	n/a	n/a	8.5	24.0

Beta Read what these cash burn values mean

Financial data from Neogen earnings reports.

Institutional ownership, Q1 2023

NEOG institutional ownership history Ownership history

97.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	351	367	-4.4%
Opened positions	46	57	-19.3%
Closed positions	62	74	-16.2%
Increased positions	119	133	-10.5%
Reduced positions	121	115	+5.2%

13F shares	Current	Prev Q	Change
Total value	3.73 tn	3.21 tn	+16.3%
Total shares	209.76 mm	225.00 mm	-6.8%
Total puts	241.60 k	127.90 k	+88.9%
Total calls	350.70 k	603.50 k	-41.9%
Total put/call ratio	0.7	0.2	+225.1%

Largest owners	Shares	Value	Change
BLK Blackrock	24.37 mm	$451.28 bn	-0.4%
Vanguard	18.53 mm	$343.26 bn	-2.7%
Wasatch Advisors	14.14 mm	$261.92 bn	-16.8%
Susquehanna Securities	8.29 mm	$0.00	0.0%
Select Equity	7.98 mm	$147.85 bn	+18.0%
STT State Street	7.56 mm	$140.09 bn	+0.3%
Brown Capital Management	5.85 mm	$108.26 bn	-11.8%
King Luther Capital Management	5.80 mm	$107.40 bn	+2.0%
MS Morgan Stanley	5.78 mm	$107.00 bn	+22.0%
Conestoga Capital Advisors	5.70 mm	$105.54 bn	+1.0%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	0.00	-18.40 mm	EXIT
Susquehanna International	4.83 mm	-3.10 mm	-39.1%
Champlain Investment Partners	3.09 mm	+3.09 mm	NEW
Wasatch Advisors	14.14 mm	-2.85 mm	-16.8%
Blair William & Co	2.40 mm	+2.40 mm	NEW
Citadel Advisors	3.46 mm	+2.02 mm	+140.6%
FMR	1.81 mm	+1.67 mm	+1157.7%
ACK Asset Management	1.59 mm	+1.59 mm	NEW
Dimensional Fund Advisors	1.14 mm	-1.35 mm	-54.2%
Select Equity	7.98 mm	+1.22 mm	+18.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NEOG insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
25 Apr 23	Adent John Edward	Common Stock	Payment of exercise	Dispose F	No	No	16.67	656	10.94 k	81,907
25 Apr 23	Douglas Edward Jones	Common Stock	Payment of exercise	Dispose F	No	No	16.67	297	4.95 k	11,857
25 Apr 23	Jerome L Hagedorn	Common Stock	Payment of exercise	Dispose F	No	No	16.67	194	3.23 k	2,571
25 Apr 23	Lilly Jason Warren	Common Stock	Payment of exercise	Dispose F	No	No	16.67	388	6.47 k	21,506
26 Jan 23	William T Boehm	Common Stock	Option exercise	Dispose M	No	No	20.08	750	15.06 k	24,509
26 Jan 23	William T Boehm	Common Stock	Option exercise	Acquire M	No	No	15.62	1,500	23.43 k	25,259
26 Jan 23	William T Boehm	Common Stock Common Stock	Option exercise	Dispose M	No	No	15.62	1,500	23.43 k	66,667